Mind Medicine Newsroom

Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital

Dow JonesDec 20 06:27 ET

Mind Medicine Initiated at Buy by Chardan Capital

Dow JonesDec 20 06:27 ET

Mind Medicine Analyst Ratings

BenzingaDec 17 11:11 ET

Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsDec 17 08:33 ET

Mind Medicine (MNMD) Receives a Buy From Oppenheimer

TipRanksDec 17 07:48 ET

RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsNov 20 10:31 ET

RBC Capital Remains a Buy on Mind Medicine (MNMD)

TipRanksNov 20 10:17 ET

Mind Medicine Analyst Ratings

BenzingaNov 11 05:21 ET

Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 9 12:32 ET

Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 9 11:31 ET

H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsNov 9 11:31 ET

Mind Medicine's Strategic Advancements and Clinical Progress Drive Buy Rating

TipRanksNov 8 12:19 ET

CCORF Maintains Mind Medicine(MNMD.US) With Buy Rating, Raises Target Price to $16

Moomoo NewsNov 8 08:32 ET

RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsNov 8 07:35 ET

RBC Capital Keeps Their Buy Rating on Mind Medicine (MNMD)

TipRanksNov 8 07:12 ET

Analysts Offer Insights on Healthcare Companies: Mind Medicine (MNMD), Knight Therapeutics (OtherKHTRF) and OnKure Therapeutics (OKUR)

TipRanksNov 8 07:12 ET

Leerink Partners Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $20

Moomoo NewsOct 11 18:31 ET

Mind Medicine Price Target Raised to $55.00/Share From $35.00 by HC Wainwright & Co.

Dow JonesAug 29 08:13 ET

Mind Medicine Is Maintained at Buy by HC Wainwright & Co.

Dow JonesAug 29 08:13 ET

Mind Medicine Analyst Ratings

BenzingaAug 29 08:04 ET